市场调查报告书
商品编码
1510701
欧洲心臟移植市场预测至 2030 年 - 区域分析 - 按手术类型(原位心臟移植和异位心臟移植)、类型(供体活体心臟和人造心臟)和最终用户(医院、心臟中心等)Europe Heart Transplant Market Forecast to 2030 - Regional Analysis - by Surgery Type (Orthotopic Heart Transplant and Heterotopic Heart Transplant), Type (Donor Live Heart and Artificial Hearts), and End User (Hospitals, Cardiac Centers, and Others) |
欧洲心臟移植市场预计将从2022年的39.7032亿美元成长到2030年的87.8967亿美元。
器官移植意识的增强推动欧洲心臟移植市场
在欧洲,提高人们对心臟移植认识的努力包括教育活动、医疗保健提供者和器官采购组织之间的合作、立法倡议以及医疗专业人员和组织的公共宣传。这些努力旨在让大众了解心臟捐赠者的迫切需求,消除担忧或误解,并鼓励个人登记为器官捐赠者。此外,医疗技术和外科技术的进步促进了心臟移植的成功和可行性,进一步凸显了器官捐赠在拯救生命的重要性。因此,欧洲国家越来越接受和理解心臟移植作为末期心臟衰竭的治疗选择。
欧洲心臟移植市场概况
欧洲心臟移植市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。欧洲在全球心臟移植市场中占据重要地位,预计 2022 年至 2030 年复合年增长率显着。导致心臟衰竭的心血管疾病的流行促进了该地区的市场成长。德国因其在医疗保健领域的持续成长和创新方法而成为一个有吸引力的市场。根据联邦统计局的数据,2021年德国的医疗支出达4,740亿美元。随着年龄的增长,许多器官开始出现故障或功能失调,导致器官移植手术。此外,据世界卫生组织称,德国约十分之四的死亡是由行为风险因素造成的,包括饮食风险、吸烟、饮酒和体力活动不足。 2021 年,德国近 19% 的成年人患有肥胖症。肥胖会引起各种其他与健康相关的问题。因此,肥胖和超重等公共卫生问题导致的慢性健康障碍可能会刺激德国对器官移植手术的需求。
德国的器官需求与器官捐赠之间存在差距。根据德国器官移植基金会 (DSO) 的数据,2021 年总共捐赠了 2,905 个死后器官,而实际需求为 8,730 个器官。因此,预计未来几年该国的器官移植手术将大幅成长。
欧洲心臟移植市场收入及 2030 年预测(百万美元)
欧洲心臟移植市场细分
欧洲心臟移植市场分为手术类型、类型、最终用户和国家。
根据手术类型,欧洲心臟移植市场分为原位心臟移植和异位心臟移植。到2022年,原位心臟移植领域将在欧洲心臟移植市场中占据更大份额。
从类型来看,欧洲心臟移植市场分为供体活体心臟和人工心臟。 2022年,供体活体心臟部分在欧洲心臟移植市场中占据较大份额。
根据最终用户,欧洲心臟移植市场分为医院、心臟中心等。 2022 年,医院细分市场在欧洲心臟移植市场中占据最大份额。
根据国家/地区,欧洲心臟移植市场分为德国、法国、英国、西班牙、义大利和欧洲其他地区。 2022年,德国将主导欧洲心臟移植市场。
Terumo Corp、Abbott Laboratories、SynCardia Systems LLC、BioVentrix Inc、Berlin Heart GmbH、LivaNova Plc 和 Calon Cardio-Technology Ltd 是欧洲心臟移植市场上的一些领先公司。
表中的内容
The Europe heart transplant market is expected to grow from US$ 3,970.32 million in 2022 to US$ 8,789.67 million by 2030. It is estimated to grow at a CAGR of 10.4% from 2022 to 2030.
Increased Awareness of Organ Transplantation Drives Europe Heart Transplant Market
In Europe, efforts to raise awareness about heart transplantation include educational campaigns, collaboration between healthcare providers and organ procurement organizations, legislative initiatives, and public advocacy from medical professionals and organizations. These efforts aim to inform the public about the critical need for heart donors, address concerns or misconceptions, and encourage individuals to register as organ donors. Additionally, advancements in medical technology and surgical techniques have contributed to the success and viability of heart transplantation, further highlighting the importance of organ donation in saving lives. As a result, there has been an increasing acceptance and understanding of heart transplantation as a treatment option for end-stage heart failure within European countries.
Europe Heart Transplant Market Overview
The Europe heart transplant market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global heart transplant market and is estimated to register a notable CAGR during 2022-2030. The prevalence of cardiovascular diseases, leading to heart failure, contributes to the market growth in the region. Germany is an attractive market due to its consistent growth and innovative approach toward the healthcare sector. According to the Federal Statistical Office, health expenditure in Germany amounted to US$ 474 billion in 2021. The rising geriatric population with the increasing prevalence of chronic disease propels the heart transplant market growth in the country. With the growing age, many organs start to malfunction or become dysfunctional giving rise to organ transplantation procedures. Further, according to the WHO, ~4 in 10 deaths in Germany result from behavioural risk factors, including dietary risks, smoking, alcohol consumption, and low physical activity. In 2021, nearly 19% adults were obese in Germany. Obesity gives rise to various other health-related problems. Thus, public health issues such as obesity and overweight, resulting in chronic health disorders, can fuel the demand for organ transplantation procedures in Germany.
There is a gap between organ demand and organ donations in Germany. According to the German Foundation for Organ Transplantation (DSO), a total of 2,905 organs were donated post-mortem in 2021, in contrast to the need for 8,730 organs. Therefore, organ transplantation procedures are expected to grow in the coming years in the country significantly.
Europe Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Europe Heart Transplant Market Segmentation
The Europe heart transplant market is segmented into surgery type, type, end user, and country.
Based on surgery type, the Europe heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart transplantation segment held a larger share of the Europe heart transplant market in 2022.
In terms of type, the Europe heart transplant market is bifurcated into donor live heart and artificial heart. The donor live heart segment held a larger share of the Europe heart transplant market in 2022. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.
Based on end user, the Europe heart transplant market is segmented into hospitals, cardiac centres, and others. The hospitals segment held the largest share of the Europe heart transplant market in 2022.
Based on country, the Europe heart transplant market is segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. Germany dominated the Europe heart transplant market in 2022.
Terumo Corp, Abbott Laboratories, SynCardia Systems LLC, BioVentrix Inc, Berlin Heart GmbH, LivaNova Plc, and Calon Cardio-Technology Ltd are some of the leading companies operating in the Europe heart transplant market.
Table of Content